Financial

News

J&J chief executive Joaquin Duato has told analysts that tax policy, not tariffs, is the key to increasing pharma manufacturing capacity in the US.

News

Things will get tougher before they get better at Bayer, according to CEO Bill Anderson, as the group reports its 2024 financial results.

News

BMS is extending its bid to cut costs by $1.5bn before the end of this year, backed by 2200 job cuts, adding a target of another $2bn by end-2027.

News

AstraZeneca's exposure to liability in a Chinese investigation into illegal drug imports appears to be much less than had been feared.

News

Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to £40 billion in 2031.

News

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.